Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.6% year on year to ...
Looking ahead, Amgen issued 2026 guidance with revenue projected between $37.0 billion and $38.4 billion, compared to the consensus estimate of $37.1 billion. The company expects adjusted EPS of ...
Stocktwits on MSN
Amgen CEO teases 2026 as ‘springboard year’ after 14 blockbusters and 18 record products
Amgen beat Q4 estimates and struck an upbeat tone for 2026. ・A broad blockbuster lineup drove 2025 performance, with 14 products generating at least $1B each in annual sales. ・Its pipeline focuses on ...
Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street ...
Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...
Investor's Business Daily on MSN
Amgen eyes buy zone after fourth-quarter beat as obesity studies mount
Amgen is running a number of studies of its obesity drug, MariTide.
The California-based biotech company's overall quarterly revenue rose 9% from a year earlier to $9.9 billion, which beat ...
Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by higher ...
Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, sending its shares ...
Analysts expect the company to post earnings of $4.76, representing a 10.4% drop from the corresponding period of the ...
Deep skin tones: Warm-toned shades like copper, gold, terracotta, or olive green.
RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results